UT San Antonio-led cancer research program could revolutionize treatment (opens in new tab)

Written by: Claire Kowalick More than 70% of cancers — including breast, bladder, cervical and lung cancer — show evidence of mutations linked to a group of enzymes called apolipoprotein B mRNA-editing enzyme catalytic polypeptides, or APOBEC. “APOBEC mutagenesis is the second-largest source of mutation in cancer and, importantly, the largest one we can do […] The post UT San Antonio-led cancer research program could revolutionize treatment appeared first on UT Health San Antonio.